Drugs / 2-Octylcyanoacrylate

Trials 2 · a red edge is where a trial was stopped

2020202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 31 trial
Phase 3 NCT04908137 Apr 2021 → Mar 2024 male reproductive system disorder The Hospital for Sick Children Unknown No outcome recorded
Phase 41 trial
Phase 4 NCT03920306 Apr 2019 → Sep 2024 gastrocutaneous syndrome University of British Columbia Completed No outcome recorded

Evidence & citations 9 cited values

Every value below carries the sentence it was read from. 3 sources stand behind the page.

FieldValueCited text
Known as 2-Octylcyanoacrylate “2. A topical adhesive of either 2-Octylcyanoacrylate glue (Dermabond), or Fibrin glue, or Histoacryl glue (Tissue Seal), will be applied over the fistula's aperture.” NCT03920306
1

NCT04908137

Known as Dermabond “2. A topical adhesive of either 2-Octylcyanoacrylate glue (Dermabond), or Fibrin glue, or Histoacryl glue (Tissue Seal), will be applied over the fistula's aperture.” NCT03920306
Known as Liquiband ChEMBL registry synonym — accepted as the source's own label CHEMBL4297544
Known as Liquid bandage ChEMBL registry synonym — accepted as the source's own label CHEMBL4297544
Known as Liquivet ChEMBL registry synonym — accepted as the source's own label CHEMBL4297544
Known as Octylseal ChEMBL registry synonym — accepted as the source's own label CHEMBL4297544
Known as Ritelok con 895 ChEMBL registry synonym — accepted as the source's own label CHEMBL4297544
Modality Small molecule CHEMBL4297544
Route Topical “2. A topical adhesive of either 2-Octylcyanoacrylate glue (Dermabond), or Fibrin glue, or Histoacryl glue (Tissue Seal), will be applied over the fistula's aperture.” NCT03920306